ACIP Endorses RSV Vaccine for At-Risk Adults 50 and Up
(MedPage Today) — The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that high-risk patients ages 50 to 59 be vaccinated for respiratory syncytial virus (RSV), and also added…
